US Patent 12084508 TRAILshort antibody and methods of use
Patent 12084508 was granted and assigned to Mayo Foundation for Medical Education and Research (MFMER) on September, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+14 properties)
Article (+445 characters)
US Patent 12084508 TRAILshort antibody and methods of use
Article
Patent abstract
This document provides antibodies against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) short, and more particularly to humanized TRAILshort antibodies that can neutralize TRAILshort. For example, materials and methods for using one or more humanized TRAILshort antibodies to induce apoptosis (e.g., via TRAIL mediated cell death, natural killer (NK) cytotoxicity, and/or CD8+ T cell killing) are provided.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Andrew D. Badley0
Date of Patent
September 10, 2024
0Patent Application Number
174108320
Date Filed
August 24, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12084508 TRAILshort antibody and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
